Coronavirus Covid-19 Distribution Economy European Hong Kong Pandemic Technology Vaccine
Moderna said it will apply for US and European emergency authorisation of its Covid-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns. It also reported a 100% success rate in preventing severe cases. The filing sets Modernaࢀ™s product up to be the second vaccine likely to receive US emergency use authorisation this year. ࢀœWe believe that we have a vaccine that is very highly efficacious. We now have the data to prove it,ࢀ Moderna chief medical officer Dr Tal Zaks said. ࢀœWe expect to be playing…
News Timeline:
Track the development of this news story across the Internet.